Bradycardia

Type: Keyphrase
Name: Bradycardia
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Banned insecticide was used to poison five dogs in Brent

Police and the RSPCA have renewed their warnings to the public, as the person responsible for poisoning five dogs - two of which died - remains at largePolice and the RSPCA have renewed their appeal for information over the poisoning of five dogs.The ... [Published GetWestLondon - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

The Subcutaneous Defibrillator A Review of the Literature

The recently commercially available subcutaneous implantable cardioverter-defibrillator (S-ICD) uses a completely subcutaneous electrode configuration to treat potentially lethal ventricular tachyarrhythmia. Clinical trials have proven its effectiveness ... [Published Journal of the American College of Cardiology - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Cardiologists: Know the signs of Lyme disease

Spring has arrived, and along with warmer weather and blossoming tree buds, a seasonal risk looms, especially for outdoor enthusiasts. The risk for Lyme disease, and the cardiac complications that can be associated with it, increases as people spend more ... [Published Orthopedics Today - Apr 14 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Cyberonics : Patent Issued for Implantable Neurostimulator-Implemented Method for Managing Bradycardia through Vagus Nerve Stimulation

By a News Reporter-Staff News Editor at Biotech Week -- A patent by the inventors Libbus, Imad ( St. Paul, MN ); Amurthur, Badri ( Los Gatos, CA ); Kenknight, Bruce H. ( Maple Grove, MN ), filed on July 20, 2012 , was published online on April 1, 2014 ... [Published 4 Traders - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI crizotinib Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive...

Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI crizotinib Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer NSCLCBy a News Reporter-Staff News Editor at Biotech Week Pfizer Inc. ... [Published Pharmacy Choice - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Surviving the Sahara – part two: Ready, set, go!

Day one update from Steve: “Brutal. This is without doubt the hardest thing I've done. It's also allegedly the hardest start in its history. We have done a total of 15 km soft dunes (the overall distance for the day was 34km). Unbelievable. Got light ... [Published Chartered Institute of Housing - Apr 08 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Do you have a slow heart rate ?

It seems that it's very hard to live healthy today. We're all running, trying to earn more money and find our place in the world. However, many of the things we do just aren't good for our health. Many just disregard that fact, and continue doing everything ... [Published Free Press Release - Apr 07 2014]
Entities: Bradycardia
First reported Apr 03 2014 - Updated Apr 04 2014 - 2 reports

New Report Documents Cardiopulmonary Arrest in Premature Infant After Cyclomydril Eyedrops

/3BL Media/ – Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for ... [Published Justmeans - Apr 03 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Pfizer : Reports Positive Phase 3 Study Outcome Of XALKORI® crizotinib Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive...

Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI® crizotinib Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer NSCLCBy a News Reporter-Staff News Editor at Biotech Week -- Pfizer Inc. ... [Published 4 Traders - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation

A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. ... [Published Free Patents Online - Apr 01 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

The risk for hyperoxaemia after apnoea, bradycardia and hypoxaemia in preterm infants

AbstractObjective To investigate the occurrence and duration of oxygen saturation (SpO 2 ) ≥95%, after extra oxygen for apnoea, bradycardia, cyanosis (ABC), and the relation with the duration of bradycardia and/orSpO 2 ≤80%.Methods All preterm infants ... [Published ADC Fetal and Neonatal - Mar 25 2014]
First reported Mar 20 2014 - Updated Mar 21 2014 - 3 reports

IJN Successfully Implants Four World's Smallest Pacemaker Devices In Patients

KUALA LUMPUR, March 20 (Bernama) -- Malaysia's National Heart Institute (IJN) has successfully implanted four of the world's smallest pacemaker devices, the Medtronic MICRA Transcatheter Pacing System (TPS), in each of its patients suffering from bradycardia ... [Published Organization of Asia-Pacific News Agencies - Mar 21 2014]
Entities: Pacemaker, Implants, Patient

Quotes

...figure out what a product actually does in the realreal world, and present a clear picture to our readers so that an informed decision can be made. "I REALLY LIKE THE FACT THAT SAMSUNG DID FOCUS ON IMPROVING WELL-KNOWN AND CRITICAL USEREALLY LIKE THE FACT THAT SAMSUNG DID FOCUS ON IMPROVING WELL-KNOWN AND CRITICAL USE CASES" Among the improvements, I really like the fact that Samsung did focus on improving well-known, critical, use cases like waterproofing the design, adding...
Reporters obtained the following quote from the background information supplied by the inventors: "Implantable medical devices are often used to treat a variety of medical conditions. Examples of implantable medical devices include drug delivery devices, pain management devices, and devices that treat heart arrhythmias. One example of an implantable medical device used to treat heart arrhythmias is a cardiac pacemaker, which is commonly implanted in a patient to treat bradycardia (i e., an abnormally slow heart rate). A pacemaker includes a pulse generator and one or more leads, which form electrical connection(s) between the pulse generator and the heart. An implantable cardioverter defibrillator (ICD) may be used to treat tachycardia (i e., an abnormally rapid heart rate). An ICD also includes a pulse generator and leads that deliver electrical energy to the heart."
Sergeant Peter Rowntree from Brent Police added: "Officers from Fryent Safer Neighbourhoods Team have been carrying out extra patrols in and around the park. I am grateful to everyone who has assisted to raise awareness regarding these incidents and I would encourage all dog walkers and the users of any of our parks, to be vigilant and phone through any suspicious activity. With better weather and longer hours of daylight the parks will be busier and I am hopeful that any criminal activity is more likely to be seen and phoned through to us."
"We were trying to find a way of dealing with opiate withdrawal and facilitate people to the next stage of addiction treatment" lead author Gregory Rudolf, MD, from the Swedish Addiction

More Content

All (114) | News (103) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (3) | Press Releases (1)
sort by: Date | Relevance
Maglana: Caving but not caving in [Published Sun Star Network - 10 hours ago]
Galaxy S5 Review [Published UberGizmo - Apr 17 2014]
Herbal cure claims for Ebola virus, dengue feve... [Published The Guardian Nigeria - Apr 17 2014]
Patent Issued for Deployable Sensor Platform on... [Published HispanicBusiness.com - Apr 16 2014]
Banned insecticide was used to poison five dogs... [Published GetWestLondon - Apr 16 2014]
Novel Nonopioid Approach Promising for Opioid D... [Published Diabetes Care - Apr 16 2014]
LifeKeeper Announce Today the Launch of the Lif... [Published Asian Hospital & Healthcare Management - Apr 15 2014]
The Subcutaneous Defibrillator A Review of the ... [Published Journal of the American College of Cardiology - Apr 15 2014]
Cardiologists: Know the signs of Lyme disease [Published Orthopedics Today - Apr 14 2014]
Chronic cough in children [Published Medical Observer - Apr 14 2014]
Youth on the Go: April 13, 2014 [Published Daily Freeman - Apr 14 2014]
Arena Pharmaceuticals Reports Eisai's Launch of... [Published Morningstar.com - Apr 14 2014]
LifeKeeper Launches the World's First Mobile De... [Published PRWeb - Apr 14 2014]
DeRisking Gilenya [Published Multiple Sclerosis Research - Apr 12 2014]
LifeKeeper Announce Today the Launch of the Lif... [Published InvestorPoint.com - Apr 10 2014]
Cyberonics : Patent Issued for Implantable Neur... [Published 4 Traders - Apr 10 2014]
Hospitals rank alarm fatigue as top patient saf... [Published Kansas City Nursing News - Apr 10 2014]
First Patient In U.S. To Receive MRI Scan In St... [Published KHTS AM-1220 - Apr 09 2014]
Pfizer Reports Positive Phase 3 Study Outcome O... [Published Pharmacy Choice - Apr 09 2014]
Steroid dose increase after CRS unnecessary to ... [Published The Clinical Advisor - Apr 09 2014]
POISE-2: ASA, Clonidine Don't Protect in Noncar... [Published General Medicine eJournal - Apr 08 2014]
Surviving the Sahara – part two: Ready, set, go! [Published Chartered Institute of Housing - Apr 08 2014]
Do you have a slow heart rate ? [Published Free Press Release - Apr 07 2014]
Nicotine poisoning in pets [Published Daily Excelsior.com - Apr 06 2014]
Bacteremia associated with increased blood crea... [Published Orthopedics Today - Apr 04 2014]
Clinic speak: fingolimod and ramblings about th... [Published Multiple Sclerosis Research - Apr 04 2014]
New Report Documents Cardiopulmonary Arrest in ... [Published Justmeans - Apr 03 2014]
New Report Documents Cardiopulmonary Arrest in ... [Published theCSRfeed - Apr 03 2014]
Pfizer : Reports Positive Phase 3 Study Outcome... [Published 4 Traders - Apr 02 2014]
Medtronic Details Findings in Cardiac Arrhythmias [Published 4 Traders - Apr 02 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
DeRisking Gilenya [Published Multiple Sclerosis Research - Apr 12 2014]
Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.  BMC Neurol. 2014;14(1):65. [Epub ...
Clinic speak: fingolimod and ramblings about th... [Published Multiple Sclerosis Research - Apr 04 2014]
Early treatment with fingolimod is better than later treatment. Why? #ClinicSpeak #MSBlog #MSResearch Have you hear about the field hypothesis of MS? #MSBlog #MSResearch "The following are the results of the second large phase 3 study of fingolimod ...
New Report Documents Cardiopulmonary Arrest in ... [Published theCSRfeed - Apr 03 2014]
Ophthalmologists Should Be Prepared for Life-Threatening Reactions During Retinopathy of Prematurity Screening, Cautions a Case Report Published in the Journal of AAPOS SOURCE: Elsevier DESCRIPTION: San Francisco, CA, April 3, 2014 /3BL Media/ – Eyedrops ...
Accidental fampridine toxicity from a compoundi... [Published Multiple Sclerosis Research - Mar 12 2014]
Compounding pharmacies; a disruptive force or a danger to our safety? #MSBlog #MSResearch When you buy slow-release fampridine you are paying for innovation; innovation costs money.  #MSBlog #MSResearch "In response to a question yesterday about cheaper ...
How oil spill chemicals cause heart failure in ... [Published EarthSky - Feb 18 2014]
Scientists at Stanford University and the National Oceanic and Atmospheric Administration (NOAA) have discovered how heart cells in fish are damaged by toxic chemicals in crude oil. They published a paper in Science, on February 14, 2014, describing ...
1 2

Press Releases

sort by: Date | Relevance
Discovery Labs Announces FDA Approval of SURFAX... [Published PR Newswire - Oct 04 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.